EcoDrugPlus

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSBSLG00000015895
Gene Symbol: RPTOR
3 Cross references
214 Possible Orthologues:

Renin-Like

Ensembl ID : ENSBSLG00000019643
Gene Symbol: LOC114858312
3 Cross references
220 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSBSLG00000007693
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSBSLG00000025583
Gene Symbol: LOC114842470
3 Cross references
211 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSBSLG00000012940
Gene Symbol: RARB
3 Cross references
394 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSBSLG00000018305
Gene Symbol: LOC114843249
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSBSLG00000010866
Gene Symbol: RARG
3 Cross references
383 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSBSLG00000003914
Gene Symbol: LOC114855534
3 Cross references
367 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSBSLG00000021802
Gene Symbol: RXRA
3 Cross references
231 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSBSLG00000013667
Gene Symbol: LOC114849611
3 Cross references
214 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSBSLG00000002383
Gene Symbol: RPL10A
3 Cross references
379 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSBSLG00000018421
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).